-
1
-
-
66949126764
-
Are BNP changes during hospitalization for heart failure a reliable surrogate for predicting the effects of therapies on post-discharge mortality?
-
19539145 10.1016/j.jacc.2009.01.075 1:CAS:528:DC%2BD1MXovFShtLs%3D
-
M Gheorghiade PS Pang 2009 Are BNP changes during hospitalization for heart failure a reliable surrogate for predicting the effects of therapies on post-discharge mortality? J Am Coll Cardiol 53 25 2349 2352 19539145 10.1016/j.jacc.2009.01.075 1:CAS:528:DC%2BD1MXovFShtLs%3D
-
(2009)
J Am Coll Cardiol
, vol.53
, Issue.25
, pp. 2349-2352
-
-
Gheorghiade, M.1
Pang, P.S.2
-
2
-
-
67651174313
-
Hotline sessions presented at the American College of Cardiology Congress 2009
-
19430713 10.1007/s00392-009-0023-3
-
LS Maier M Baumhakel M Bohm 2009 Hotline sessions presented at the American College of Cardiology Congress 2009 Clin Res Cardiol 98 6 345 352 19430713 10.1007/s00392-009-0023-3
-
(2009)
Clin Res Cardiol
, vol.98
, Issue.6
, pp. 345-352
-
-
Maier, L.S.1
Baumhakel, M.2
Bohm, M.3
-
3
-
-
65249190276
-
Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): A multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study
-
19329178 10.1016/S0140-6736(09)60622-X 1:CAS:528:DC%2BD1MXltVCqtbk%3D
-
JR Teerlink M Metra GM Felker P Ponikowski AA Voors BD Weatherley, et al. 2009 Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study Lancet 373 9673 1429 1439 19329178 10.1016/S0140-6736(09)60622-X 1:CAS:528:DC%2BD1MXltVCqtbk%3D
-
(2009)
Lancet
, vol.373
, Issue.9673
, pp. 1429-1439
-
-
Teerlink, J.R.1
Metra, M.2
Felker, G.M.3
Ponikowski, P.4
Voors, A.A.5
Weatherley, B.D.6
-
4
-
-
0036023202
-
African-American Heart Failure Trial (A-HeFT): Rationale, design, and methodology
-
DOI 10.1054/jcaf.2002.124730
-
JA Franciosa AL Taylor JN Cohn CW Yancy S Ziesche A Olukotun, et al. 2002 African-American Heart Failure Trial (A-HeFT): rationale, design, and methodology J Card Fail 8 3 128 135 12140804 10.1054/jcaf.2002.124730 (Pubitemid 34857277)
-
(2002)
Journal of Cardiac Failure
, vol.8
, Issue.3
, pp. 128-135
-
-
Franciosa, J.A.1
Taylor, A.L.2
Cohn, J.N.3
Yancy, C.W.4
Ziesche, S.5
Olukotun, A.6
Ofili, E.7
Ferdinand, K.8
Loscalzo, J.9
Worcel, M.10
-
5
-
-
44349154267
-
A Global Ranking Approach to End Points in Trials of Mechanical Circulatory Support Devices
-
DOI 10.1016/j.cardfail.2008.01.009, PII S1071916408000274
-
GM Felker KJ Anstrom JG Rogers 2008 A global ranking approach to end points in trials of mechanical circulatory support devices J Card Fail 14 5 368 372 18514927 10.1016/j.cardfail.2008.01.009 (Pubitemid 351749834)
-
(2008)
Journal of Cardiac Failure
, vol.14
, Issue.5
, pp. 368-372
-
-
Felker, G.M.1
Anstrom, K.J.2
Rogers, J.G.3
-
6
-
-
67649977368
-
End points for clinical trials in acute heart failure syndromes
-
19520247 10.1016/j.jacc.2008.12.079
-
LA Allen AF Hernandez CM O'Connor GM Felker 2009 End points for clinical trials in acute heart failure syndromes J Am Coll Cardiol 53 24 2248 2258 19520247 10.1016/j.jacc.2008.12.079
-
(2009)
J Am Coll Cardiol
, vol.53
, Issue.24
, pp. 2248-2258
-
-
Allen, L.A.1
Hernandez, A.F.2
O'Connor, C.M.3
Felker, G.M.4
-
7
-
-
29444454634
-
Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE
-
DOI 10.1016/j.ejheart.2005.12.003, PII S1388984205003466
-
JG Cleland N Freemantle AP Coletta AL Clark 2006 Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE Eur J Heart Fail 8 1 105 110 16387630 10.1016/j.ejheart.2005.12.003 1:CAS:528:DC%2BD28XkvFWn (Pubitemid 43012109)
-
(2006)
European Journal of Heart Failure
, vol.8
, Issue.1
, pp. 105-110
-
-
Cleland, J.G.F.1
Freemantle, N.2
Coletta, A.P.3
Clark, A.L.4
-
8
-
-
52949105070
-
The PROTECT pilot study: A randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment
-
18926433 10.1016/j.cardfail.2008.08.010 1:CAS:528:DC%2BD1cXhtFOrtLvK
-
G Cotter HC Dittrich BD Weatherley DM Bloomfield CM O'Connor M Metra, et al. 2008 The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment J Card Fail 14 8 631 640 18926433 10.1016/j.cardfail.2008.08.010 1:CAS:528:DC%2BD1cXhtFOrtLvK
-
(2008)
J Card Fail
, vol.14
, Issue.8
, pp. 631-640
-
-
Cotter, G.1
Dittrich, H.C.2
Weatherley, B.D.3
Bloomfield, D.M.4
O'Connor, C.M.5
Metra, M.6
-
9
-
-
77957730950
-
Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure
-
20925544 10.1056/NEJMoa0912613
-
BM Massie CM O'Connor M Metra P Ponikowski JR Teerlink G Cotter, et al. 2010 Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure N Engl J Med 363 15 1419 1428 20925544 10.1056/NEJMoa0912613
-
(2010)
N Engl J Med
, vol.363
, Issue.15
, pp. 1419-1428
-
-
Massie, B.M.1
O'Connor, C.M.2
Metra, M.3
Ponikowski, P.4
Teerlink, J.R.5
Cotter, G.6
-
10
-
-
44449114156
-
Design of a Phase 1/2 Trial of Intracoronary Administration of AAV1/SERCA2a in Patients With Heart Failure
-
DOI 10.1016/j.cardfail.2008.02.005, PII S1071916408000626
-
RJ Hajjar K Zsebo L Deckelbaum C Thompson J Rudy A Yaroshinsky, et al. 2008 Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure J Card Fail 14 5 355 367 18514926 10.1016/j.cardfail.2008.02.005 1:CAS:528:DC%2BD1cXms1Wksrw%3D (Pubitemid 351756538)
-
(2008)
Journal of Cardiac Failure
, vol.14
, Issue.5
, pp. 355-367
-
-
Hajjar, R.J.1
Zsebo, K.2
Deckelbaum, L.3
Thompson, C.4
Rudy, J.5
Yaroshinsky, A.6
Ly, H.7
Kawase, Y.8
Wagner, K.9
Borow, K.10
Jaski, B.11
London, B.12
Greenberg, B.13
Pauly, D.F.14
Patten, R.15
Starling, R.16
Mancini, D.17
Jessup, M.18
-
11
-
-
0021666221
-
Procedures for comparing samples with multiple endpoints
-
6534410 10.2307/2531158
-
PC O'Brien 1984 Procedures for comparing samples with multiple endpoints Biometrics 40 4 1079 1087 6534410 10.2307/2531158
-
(1984)
Biometrics
, vol.40
, Issue.4
, pp. 1079-1087
-
-
O'Brien, P.C.1
-
12
-
-
0025882782
-
Procedures for two-sample comparisons with multiple endpoints controlling the experimentwise error rate
-
1912258 10.2307/2532142 1:STN:280:DyaK38%2FgtlWjuw%3D%3D
-
W Lehmacher G Wassmer P Reitmeir 1991 Procedures for two-sample comparisons with multiple endpoints controlling the experimentwise error rate Biometrics 47 2 511 521 1912258 10.2307/2532142 1:STN:280:DyaK38%2FgtlWjuw%3D%3D
-
(1991)
Biometrics
, vol.47
, Issue.2
, pp. 511-521
-
-
Lehmacher, W.1
Wassmer, G.2
Reitmeir, P.3
-
13
-
-
64949097265
-
Advancing care for acute heart failure-no time to relax
-
19329180 10.1016/S0140-6736(09)60653-X
-
AF Hernandez CB Granger 2009 Advancing care for acute heart failure-no time to relax Lancet 373 9673 1401 1402 19329180 10.1016/S0140-6736(09)60653-X
-
(2009)
Lancet
, vol.373
, Issue.9673
, pp. 1401-1402
-
-
Hernandez, A.F.1
Granger, C.B.2
-
14
-
-
77951683693
-
Sample size calculations for crossover thorough QT studies: Satisfaction of regulatory threshold and assay sensitivity
-
20358438 10.1080/10543400903582000
-
SP Anand SC Murray GG Koch 2010 Sample size calculations for crossover thorough QT studies: satisfaction of regulatory threshold and assay sensitivity J Biopharm Stat 20 3 587 603 20358438 10.1080/10543400903582000
-
(2010)
J Biopharm Stat
, vol.20
, Issue.3
, pp. 587-603
-
-
Anand, S.P.1
Murray, S.C.2
Koch, G.G.3
-
15
-
-
77951891036
-
Clinical trials of pharmacological therapies in acute heart failure syndromes: Lessons learned and directions forward
-
20233993 10.1161/CIRCHEARTFAILURE.109.893222
-
GM Felker PS Pang KF Adams JG Cleland G Cotter K Dickstein, et al. 2010 Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward Circ Heart Fail 3 2 314 325 20233993 10.1161/CIRCHEARTFAILURE.109.893222
-
(2010)
Circ Heart Fail
, vol.3
, Issue.2
, pp. 314-325
-
-
Felker, G.M.1
Pang, P.S.2
Adams, K.F.3
Cleland, J.G.4
Cotter, G.5
Dickstein, K.6
-
16
-
-
77957139942
-
Acute heart failure clinical drug development: From planning to proof of activity to Phase III
-
20881385 10.1159/000318048
-
G Cotter AA Voors BD Weatherley PS Pang JR Teerlink G Filippatos, et al. 2010 Acute heart failure clinical drug development: from planning to proof of activity to Phase III Cardiology 116 4 292 301 20881385 10.1159/000318048
-
(2010)
Cardiology
, vol.116
, Issue.4
, pp. 292-301
-
-
Cotter, G.1
Voors, A.A.2
Weatherley, B.D.3
Pang, P.S.4
Teerlink, J.R.5
Filippatos, G.6
-
17
-
-
0027238592
-
The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials
-
DT Felson JJ Anderson M Boers C Bombardier M Chernoff B Fried, et al. 1993 The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials Arthritis Rheum 36 6 729 740 8507213 10.1002/art.1780360601 1:STN:280:DyaK3s3ot1ylsQ%3D%3D (Pubitemid 23175613)
-
(1993)
Arthritis and Rheumatism
, vol.36
, Issue.6
, pp. 729-740
-
-
Felson, D.T.1
Anderson, J.J.2
Boers, M.3
Bombardier, C.4
Chernoff, M.5
Fried, B.6
Furst, D.7
Goldsmith, C.8
Kieszak, S.9
Lightfoot, R.10
Paulus, H.11
Tugwell, P.12
Weinblatt, M.13
Widmark, R.14
Williams, H.J.15
Wolfe, F.16
|